IDEX BIOMETRICS ASA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.928 NOK | +0.83% |
|
-2.94% | -30.14% |
| Apr. 02 | Mutual Trust Bank Launches Biometric Cards with IDEX Biometrics in Bangladesh | CI |
| Mar. 15 | IDEX Biometrics Receives IDEX Access Production Order from Sentry Enterprises | CI |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 1,652 | 919 | 2,480 | 3,193 | 1,166 | 540.1 | 540.1 |
| Enterprise Value (EV) 1 | 1,568 | 919 | 2,480 | 3,193 | 1,166 | 771.1 | 540.1 |
| P/E ratio | -6.74 x | -2.67 x | -11.8 x | -8.73 x | -3.23 x | -2.36 x | -9.41 x |
| Yield | - | - | - | - | - | - | - |
| Capitalization / Revenue | 461 x | 247 x | 269 x | 128 x | 27.7 x | 17.6 x | 1.17 x |
| EV / Revenue | 461 x | 247 x | 269 x | 128 x | 27.7 x | 17.6 x | 1.17 x |
| EV / EBITDA | -6.98 x | - | -11.7 x | -12.2 x | -4.07 x | -2.92 x | 211 x |
| EV / FCF | -7,395,842 x | - | -12,585,235 x | - | - | - | - |
| FCF Yield | -0% | - | -0% | - | - | - | - |
| Price to Book | 13.4 x | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 108,863 | 143,598 | 166,429 | 202,078 | 233,265 | 280,127 | 280,127 |
| Reference price 2 | 15.18 | 6.400 | 14.90 | 15.80 | 4.998 | 1.928 | 1.928 |
| Announcement Date | 2/27/19 | 2/27/20 | 2/25/21 | 2/24/22 | 2/22/23 | 2/29/24 | - |
1NOK in Million2NOK
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 3.585 | 3.724 | 9.231 | 24.87 | 42.02 | 43.93 | 459.9 |
| EBITDA 1 | -236.7 | - | -212.7 | -262.5 | -286.1 | -264.3 | 2.555 |
| EBIT 1 | -243.5 | - | -214.1 | -278.5 | -322.2 | -296.5 | -48.55 |
| Operating Margin | -6,792.52% | - | -2,319.82% | -1,119.64% | -766.78% | -674.88% | -10.56% |
| Earnings before Tax (EBT) 1 | -245.8 | - | -226.4 | -288.4 | -335.8 | -282.9 | -48.55 |
| Net income 1 | -246.1 | - | -225.5 | -289.2 | -335.5 | -282.7 | -49.57 |
| Net margin | -6,864.63% | - | -2,443.29% | -1,162.57% | -798.39% | -643.52% | -10.78% |
| EPS 2 | -2.250 | -2.400 | -1.259 | -1.809 | -1.549 | -1.168 | -0.2050 |
| Free Cash Flow | -223.4 | - | -197 | - | - | - | - |
| FCF margin | -6,230.63% | - | -2,134.61% | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 2/27/19 | 2/27/20 | 2/25/21 | 2/24/22 | 2/22/23 | 2/29/24 | - |
1NOK in Million2NOK
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 6.18 | 6.244 | 6.992 | 9.571 | 10.54 | 9.399 | 10.95 | 13.54 | 14.97 | 10.57 | 5.139 |
| EBITDA 1 | -61.47 | -59.71 | - | -67.45 | -70.17 | -74.99 | -63.89 | -72.66 | -67.98 | -68.38 | -49.43 |
| EBIT 1 | -65.55 | -63.64 | -80.18 | -77.43 | -79.02 | -82.25 | -71.27 | -80.74 | -75.41 | -75.3 | -58.57 |
| Operating Margin | -1,060.69% | -1,019.13% | -1,146.76% | -809% | -749.82% | -875.11% | -650.94% | -596.38% | -503.69% | -712.42% | -1,139.72% |
| Earnings before Tax (EBT) 1 | -64.16 | -63.71 | -90.86 | -78.59 | -87.92 | -91.4 | -64.8 | -78.85 | -76.48 | -78.27 | -52.05 |
| Net income 1 | -64.16 | -63.71 | -91.66 | -78.59 | -87.92 | -91.4 | -64.43 | -78.9 | -76.17 | -78.22 | -52.21 |
| Net margin | -1,038.16% | -1,020.36% | -1,311.05% | -821.13% | -834.3% | -972.41% | -588.46% | -582.77% | -508.75% | -740% | -1,016.11% |
| EPS 2 | - | -0.4282 | -0.9047 | -0.4922 | - | -0.5064 | - | -0.5470 | -0.5110 | -0.5563 | -0.2123 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 8/12/21 | 11/4/21 | 2/24/22 | 5/12/22 | 8/11/22 | 11/10/22 | 2/22/23 | 5/23/23 | 8/10/23 | 11/9/23 | 2/29/24 |
1NOK in Million2NOK
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Net Cash position | 83.7 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow | -223 | - | -197 | - | - | - | - |
| ROE (net income / shareholders' equity) | -107% | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - |
| Book Value Per Share | 1.130 | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - |
| Capex | 8.99 | - | - | - | - | - | - |
| Capex / Sales | 250.79% | - | - | - | - | - | - |
| Announcement Date | 2/27/19 | 2/27/20 | 2/25/21 | 2/24/22 | 2/22/23 | 2/29/24 | - |
1NOK in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -30.14% | 48.91M | |
| -25.52% | 1.55B | |
| +186.73% | 161M | |
| +14.63% | 120M | |
| -44.01% | 53.47M |
- Stock Market
- Equities
- IDEX Stock
- Financials IDEX Biometrics ASA
